Skip to main content
Year archive

METABIOMED.CO.,LTD — 2022 filings

All 26 regulatory filings released by METABIOMED.CO.,LTD (059210) in 2022, sourced directly from the official regulator.

26 Filings
2022 Period
2022 filings (26)
Filing Released Lang
[기재정정]신규시설투자등
Regulatory Filings
2022-12-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-14 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-06 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-05 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-11 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares
2022-09-30 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2022-09-08 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-12 Korean
[기재정정]사업보고서 (2021.12)
Annual Report FY 2021
2022-08-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-07-06 Korean
[기재정정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2022-06-30 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2022-06-29 Korean
신규시설투자등
Share Issue/Capital Change
2022-05-27 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-28 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-18 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-18 Korean
[연장결정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares
2022-03-16 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-15 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-03-11 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2022-03-11 Korean
주주총회소집결의
AGM Information
2022-03-11 Korean
주주총회소집공고
AGM Information
2022-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2022-03-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-01-28 Korean